Servier acquires Symphogen to pick up oncology pipeline 07-Apr-2020 By Ben Hargreaves Servier buy outs its former partner to bolster its antibody discovery and development capabilities within oncology.
July roundup sees flurry of partnership deals 29-Jul-2019 By Ben Hargreaves The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.
Servier taps Pall for biomanufacturing facility operations set-up 23-Jul-2019 By Maggie Lynch Pall works with Servier to get the latter’s oncology drug production and biomanufacturing up and running to support its Bio-S project.
